Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study

Youn Zoo Cho, So Yeon Park, Eun Hee Choi, Soon Koo Baik, Sang Ok Kwon, Young Ju Kim, Seung Hwan Cha, Moon Young Kim

Clin Mol Hepatol. 2015;21(2):165-174. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.165

View: 9273 Download: 94 Web of Science: 17 Crossref: 17

Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis

Yoon Ok Jang, Baek Gyu Jun, Soon Koo Baik, Moon Young Kim, Sang Ok Kwon

Clin Mol Hepatol. 2015;21(2):141-149. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.141

View: 9360 Download: 135 Web of Science: 44 Crossref: 40

Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension

Jae Hyun Kim, Jung Min Kim, Youn Zoo Cho, Ji Hoon Na, Hyun Sik Kim, Hyoun A Kim, Hye Won Kang, Soon Koo Baik, Sang Ok Kwon, Seung Hwan Cha, Young Ju Kim, Moon Young Kim

Clin Mol Hepatol. 2014;20(4):376-383. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.376

View: 8995 Download: 80 Web of Science: 18 Crossref: 18

Case Report

Three cases of glycogenic hepatopathy mimicking acute and relapsing hepatitis in type I diabetes mellitus

Jae Hwang Cha, Sang Ho Ra, Yu Mi Park, Yong Kwan Ji, Ji Hyun Lee, So Yeon Park, Soon Koo Baik, Sang Ok Kwon, Mee Yon Cho, Moon Young Kim

Clin Mol Hepatol. 2013;19(4):421-425. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.421

View: 7929 Download: 78 Crossref: 22

Original Article

The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data

Won Ki Hong, Moon Young Kim, Soon Koo Baik, Seung Yong Shin, Jung Min Kim, Yong Seok Kang, Yoo Li Lim, Young Ju Kim, Youn Zoo Cho, Hye Won Hwang, Jin Hyung Lee, Myeong Hun Chae, Hyoun A Kim, Hye Won Kang, Sang Ok Kwon

Clin Mol Hepatol. 2013;19(4):370-375. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.370

View: 8464 Download: 102 Crossref: 42

Ultrasonographic scoring system score versus liver stiffness measurement in prediction of cirrhosis

Kyoung Min Moon, Gaeun Kim, Soon Koo Baik, Eunhee Choi, Moon Young Kim, Hyoun A Kim, Mee Yon Cho, Seung Yong Shin, Jung Min Kim, Hong Jun Park, Sang Ok Kwon, Young Woo Eom

Clin Mol Hepatol. 2013;19(4):389-398. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.389

View: 10012 Download: 88 Crossref: 34

Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis

Moon Young Kim, Soon Koo Baik, Chan Sik Won, Hong Jun Park, Hyo Keun Jeon, Hyun Il Hong, Jae Woo Kim, Hyun Soo Kim, Sang Ok Kwon, Jang Young Kim, Byung Su Yoo, Seung Hwan Lee

Clin Mol Hepatol. 2010;16(4):376-382. Published online December 31, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.4.376

View: 8361 Download: 78 Crossref: 26

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5406	MAFLD: How is it different from NAFLD?
Viewed By 5215	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5095	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4727	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Author :

Author index